cadenas
  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-066 LOXO 101

A Phase I/II Study of the Oral TRK Inhibitor LOXO 101 in Pediatric Patients with Advanced Solid or Primary Central Nervous System Tumors

Promotor Name : LOXO ONCOLOGY

Investigator Name : G. BISOGNIO

Trial registered on clinicaltrial.gov: NCT02637687